Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based company, which is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing drugs and delivery methods. The Company seeks to develop ketamine and derivatives and other psychedelic products from its Internet protocol (IP... see more

Recent & Breaking News (CSE:BRAX)

Champignon Selected as Headline Partner for PSYCH: The Psychedelics Symposium at Prohibition Partners LIVE

GlobeNewswire April 28, 2020

Champignon Commences U.S. Trading on the OTCQB Venture Market Under Ticker Symbol "SHRMF"

GlobeNewswire April 23, 2020

REPEAT - Champignon Secures Stable Psilocybin Supply Under DEA Schedule I License for TBI/PTSD Studies at the University of Miami

GlobeNewswire April 22, 2020

Champignon Secures Stable Psilocybin Supply Under DEA Schedule I License for TBI/PTSD Studies at the University of Miami

GlobeNewswire April 22, 2020

Champignon Receives DTC Eligibility

GlobeNewswire April 17, 2020

REPEAT - Champignon Appoints Former President of Red Bull Canada to Special Advisory Committee

GlobeNewswire April 16, 2020

Champignon Appoints Former President of Red Bull Canada to Special Advisory Committee

GlobeNewswire April 16, 2020

REPEAT - CHAMPIGNON TO ACQUIRE ALTMED CAPITAL CORP., CONTRIBUTING HEALTH CANADA'S ONLY APPROVED PSYCHEDELIC MEDICINE CLINIC, SOPs FOR CLINICAL EXPANSION, EXISTING IP & MULTIPLE TRIALS

GlobeNewswire April 13, 2020

CHAMPIGNON TO ACQUIRE ALTMED CAPITAL CORP., CONTRIBUTING HEALTH CANADA'S ONLY APPROVED PSYCHEDELIC MEDICINE CLINIC, SOPs FOR CLINICAL EXPANSION, EXISTING IP & MULTIPLE TRIALS

GlobeNewswire April 9, 2020

Champignon Featured in Broadcast on Mental Health Options, Medical Mushrooms

GlobeNewswire April 3, 2020

Champignon Brands Spotlighted in Publication Discussing Potential of Mushrooms in Medicine

GlobeNewswire April 1, 2020

REPEAT - CHAMPIGNON APPOINTS UNIVERSITY OF TORONTO CLINICAL ADVISOR, PHARMACOGNOSIST TO SPECIAL ADVISORY COMMITTEE

GlobeNewswire March 31, 2020

CHAMPIGNON APPOINTS UNIVERSITY OF TORONTO CLINICAL ADVISOR, PHARMACOGNOSIST TO SPECIAL ADVISORY COMMITTEE

GlobeNewswire March 31, 2020

REPEAT - CHAMPIGNON EXPANDS PRECLINICAL PIPELINE WITH MEASURED PSILOCYBIN DOSAGES STUDIES AT UNIVERSITY OF MIAMI

GlobeNewswire March 30, 2020

CHAMPIGNON EXPANDS PRECLINICAL PIPELINE WITH MEASURED PSILOCYBIN DOSAGES STUDIES AT UNIVERSITY OF MIAMI

GlobeNewswire March 27, 2020

REPEAT - CHAMPIGNON BRANDS APPOINTS DR. JOSEPH GABRIELE, ERNST & YOUNG 2018 HEALTH CARE ENTREPRENEUR OF THE YEAR AND DELIVRA(TM) INVENTOR TO SPECIAL ADVISORY COMMITTEE

GlobeNewswire March 25, 2020

CHAMPIGNON BRANDS APPOINTS DR. JOSEPH GABRIELE, ERNST & YOUNG 2018 HEALTH CARE ENTREPRENEUR OF THE YEAR AND DELIVRA(TM) INVENTOR TO SPECIAL ADVISORY COMMITTEE

GlobeNewswire March 25, 2020

CEO of Champignon Brands Shares Strategic Goals in Exclusive NetworkNewsWire Broadcast

GlobeNewswire March 23, 2020

CHAMPIGNON BRANDS ANNOUNCES NORMAL COURSE ISSUER BID FOR COMMON SHARES OF THE CORPORATION

GlobeNewswire March 20, 2020

Champignon Grows IP Portfolio with Latest Acquisition

Stockhouse Editorial March 20, 2020